RxSight Inc. (RXST)
NASDAQ: RXST
· Real-Time Price · USD
13.02
-0.21 (-1.59%)
At close: Jun 27, 2025, 11:37 AM
RxSight Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2021 |
|---|---|---|
| L D D Revenue | 39.7M | 13.77M |
| L D D Revenue Growth | +188.25% | n/a |
| RxLAL Revenue | 96.5M | 656K |
| RxLAL Revenue Growth | +14609.91% | n/a |
| Service Warranty Service Contracts And Accessories Revenue | 3.73M | n/a |
| Service Warranty Service Contracts And Accessories Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.64M | 28.21M | 25.61M | 24.29M | 23.32M | 21.16M | 19.14M | 18.24M | 16.25M | 15.73M | 14.93M | 14.39M | 13.62M | 11.62M | 9.08M | 6.5M | 5.61M | 4.4M | 3.83M | 3.25M | 3.7M |
| Selling, General, and Administrative Revenue Growth | +1.51% | +10.16% | +5.42% | +4.15% | +10.20% | +10.57% | +4.95% | +12.21% | +3.33% | +5.39% | +3.74% | +5.64% | +17.22% | +28.02% | +39.59% | +15.88% | +27.44% | +15.11% | +17.73% | -12.14% | n/a |
| Research and Development Revenue | 10.37M | 9.21M | 8.84M | 8.29M | 8.03M | 7.34M | 7.1M | 7.4M | 7.21M | 6.68M | 6.39M | 6.19M | 6.72M | 5.92M | 5.38M | 6.56M | 6.64M | 5.27M | 5.8M | 5.08M | 5.78M |
| Research and Development Revenue Growth | +12.60% | +4.18% | +6.60% | +3.24% | +9.40% | +3.38% | -4.05% | +2.68% | +7.89% | +4.59% | +3.17% | -7.84% | +13.57% | +10.02% | -18.07% | -1.20% | +26.01% | -9.12% | +14.10% | -12.00% | n/a |